Science Premium

After allowing the human clinical trial of the indigenous vaccine Covaxin and ZyCov-D for the corona virus in India, the government said it was 'the beginning of the end of the corona'.

The Union Ministry of Science and Technology in India has said in its letter that more than 100 vaccines are being tested all over the world and only 11 of them are undergoing human trials.

"The human trials of the vaccine will begin after getting permission from the Drug Controller General of India, which is the beginning of an end," the ministry letter said.

Six Indian companies are working on the Kovid-19 vaccine. Out of 140 vaccines across the world, 11 are undergoing human trials including two Indian vaccines Covaxin and ZyCov-D.

Usually the first two stages of a drug test are about safety while the third phase is about the effect of the drug.

Each phase can take months to years to complete.

The letter from the ministry came at a time when there was a dispute over deciding the last date of release of the ICMR vaccine to 15 August.

However, ICMR has now made it clear that the vaccine will come on the market only on the basis of global regulations.

Among the two indigenous vaccines that have been allowed to undergo human trials in India are Covaxin of Bharat Biotech and ZyCov-D of Zaedus Cadila.

Permission for first and second phase testing was received this week.

Plasma bank has recently been started in Delhi to deal with the corona epidemic. Plasma therapy was approved for treatment of corona virus patients. Now it is also being used in the treatment of patients with critical condition.

It is the first plasma bank in India to treat corona. It is built in the Bank Institute of Liver and Biliary Science (ILBC) Hospital. The plasma bank is expected to make it easier for patients to get plasma.

In such a situation, appeals are being made to donate the plasma to cured patients of Covid-19. However, not every corona virus patient can donate plasma. Some conditions have been laid for this.

It has been reported that she has become a mother anytime in her life and currently pregnant women cannot donate plasma.

ILBS director AK Sarin told in an interview to Hindustan Times, an English newspaper, that plasma cannot be taken from pregnant women and pregnant women. Their plasma can do more harm to the Covid-19 patient.

The World Health Organization said Saturday that hydroxychloroquine and lopinavir / ritonavir are being discontinued on corona-infected patients.

The hydroxychloroquine used to treat malaria and the lopinavir / ritonavir drug given to HIV patients did not succeed in preventing mortality of corona infectives, after which the decision has been taken.

The drug was seen as an expectation in different vaccine and medicine trials in search of treatment for corona and this bad news has come at a time when the World Health Organization itself has reported that for the first time worldwide More than two lakh corona infection cases have been reported in a single day.

On Friday, there were 212,326 reported cases of corona infection worldwide, with 53,213 cases reported in the US alone.

The World Health Organization said in a statement, "The results from the medical trial showed that the use of hydroxychloroquine and lopinavir / ritonavir reduced the mortality rate of hospitalized corona patients by little or no. Therefore, trial of these drugs will be stopped with immediate effect.

In different countries of the world, the effect of these drugs on corona patients under the leadership of the World Health Organization was being investigated.

The United Nations Health Agency said that the decision has been taken based on the recommendation of an international committee.

However, the WHO has clarified that patients who are not hospitalized and who use them as a preventive treatment will not be affected by this decision.